Rett syndrome clinical trials

Other conditions

19 trials are recruiting, according to ClinicalTrials.gov.

Checked against the registry on 22 November 2026. Listing a trial here is not a recommendation; taking part is voluntary and each study team decides who is eligible.

Recruiting · Phase 3 · Listed on Beacon

A Phase 3 Study of Fenfluramine Hydrochloride in Rett Syndrome

Ages 5 Years to 35 Years · 46 sites · UCB BIOSCIENCES, Inc.

Details and how to check if you qualify · NCT07503444 on ClinicalTrials.gov

Not yet recruiting · Phase 2 / Phase 3

Efficacy and Safety of NTI164 in Children and Young Adults With Rett Syndrome

Ages 4 Years to 25 Years · 1 site · Fenix Innovation Group

NCT07257978 on ClinicalTrials.gov

Recruiting · Phase 3

To Investigate the Efficacy of Treatment With Oral NA-921 (Bionetide) Versus Placebo in Females With Rett Syndrome

Ages 5 Years to 20 Years · 18 sites · Biomed Industries, Inc.

NCT06840496 on ClinicalTrials.gov

Recruiting · Phase 2

A Pilot Study of an Antioxidant Cocktail vs. Placebo in the Treatment of Children and Adolescents With Rett Syndrome

Ages 2 Years to 21 Years · 1 site · Holland Bloorview Kids Rehabilitation Hospital

NCT04041713 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Adapting a Psychosocial Support Intervention for the Rett Syndrome Community

Ages 18 Years to no maximum · 1 site · Colorado State University

NCT07730112 on ClinicalTrials.gov

Recruiting · Phase 1

Rett REVOLUTION Trial: An Exploratory Evaluation of the Safety and Efficacy of Vorinostat in Rett Syndrome

Ages 6 Years to 21 Years · 1 site · Unravel Biosciences, Inc.

NCT07150013 on ClinicalTrials.gov

Recruiting · Not applicable

Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disorders

Ages 4 Years to 12 Years · 1 site · Healing Hope International

NCT07493096 on ClinicalTrials.gov

Enrolling by invitation · Phase 2

Lamivudine as a Novel Clinical Effort for Rett Syndrome

Ages 2 Years to no maximum · 1 site · Maria Denise Fernandes Carvalho de Andrade

NCT07640503 on ClinicalTrials.gov

Recruiting · Not applicable

Auditory EEG and Behavioral Assessments in Individuals With Rett Syndrome

Ages 2 Years to no maximum · 1 site · University of Rochester

NCT07569445 on ClinicalTrials.gov

Recruiting · Phase 2

Repurposing Mirtazapine in Rett Syndrome

Ages 5 Years to 40 Years · 4 sites · University of Trieste

NCT07430046 on ClinicalTrials.gov

Recruiting · Not applicable

Cognitive Function in Rett Syndrome During Trofinetide Treatment

Ages 18 Years to 99 Years · 1 site · University of Minnesota

NCT06705816 on ClinicalTrials.gov

Enrolling by invitation · Not applicable

GCB-002 in Treatment of Patients With Rett Syndrome

Ages 2 Years to 10 Years · 1 site · Genecombio Ltd.

NCT06739434 on ClinicalTrials.gov

Recruiting · Phase 1 / Phase 2

ATTUNE: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intrathecally-Administered ION440 in Participants With Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome (MDS)

Ages 2 Years to 65 Years · 12 sites · Ionis Pharmaceuticals, Inc.

NCT06430385 on ClinicalTrials.gov

Recruiting · Not applicable

Neurophysiologic Biomarkers in Rett Syndrome

Ages 1 Year to 18 Years · 6 sites · Children's Hospital of Philadelphia

NCT05932589 on ClinicalTrials.gov

Recruiting · Not applicable

Rett Syndrome Registry

Ages 0 Years to 99 Years · 19 sites · International Rett Syndrome Foundation

NCT05432349 on ClinicalTrials.gov

Recruiting · Not applicable

The Rett Syndrome Global Registry

Ages No minimum to no maximum · 1 site · Rett Syndrome Research Trust

NCT04900493 on ClinicalTrials.gov

Recruiting · Not applicable

Gene Editing as a Therapeutic Approach for Rett Syndrome

Ages 6 Months to no maximum · 1 site · University of Siena

NCT05740761 on ClinicalTrials.gov

Enrolling by invitation · Not applicable

Parent and Infant Inter(X)Action Intervention (PIXI)

Ages No minimum to 99 Years · 1 site · RTI International

NCT03836300 on ClinicalTrials.gov

Recruiting · Not applicable

GROWing Up With Rare GENEtic Syndromes

Ages 18 Years to no maximum · 1 site · dr. Laura C. G. de Graaff-Herder

NCT04463316 on ClinicalTrials.gov

More: Acne clinical trials · Alzheimer’s disease and related dementias clinical trials · Cannabis use disorder clinical trials · Chronic hives (chronic urticaria) clinical trials · COPD (chronic obstructive pulmonary disease) clinical trials · Depression clinical trials · Depression (major depressive disorder) clinical trials · Moderately to severely active crohn's disease clinical trials · Osteoporosis clinical trials